Stereotaxis to Demonstrate Advanced Coronary & Peripheral Navigation, CTO
Vessel Road Mapping at TCT 2007
Stereotaxis' Mobile Vascular Showroom at Booth 8093
ST. LOUIS, Oct. 19 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS) announced today that it will be showcasing the interventional cardiology capabilities of its Niobe(R) Magnetic Navigation System at the Transcatheter Cardiovascular Therapeutics (TCT) symposium in Washington D.C., October 20 to 25, 2007. Demonstrations in Stereotaxis' Mobile Vascular Lab, the presentation of new clinical data and a live case presentation will underscore the simplicity, safety and precision that Stereotaxis can bring to a variety of vascular interventions.
The Stereotaxis system utilizes advanced, magnet-guided navigational technology designed to help interventional cardiologists perform interventional procedures with enhanced safety and precision. With systems installed at more than 70 leading hospitals worldwide, physicians have used the Stereotaxis system to perform over 2,000 percutaneous coronary interventions (PCI) and other guide wire-based vascular procedures, as well as more than 8,000 complex electrophysiology mapping and ablation procedures, on the left and right sides of the heart.
Stereotaxis will host a breakfast symposium at TCT on Tuesday, October 23, 2007 at 7:00 a.m., in Room 144C, at which leading, distinguished interventional cardiologists will present their clinical experiences using the Niobe system for percutaneous coronary interventions as well as total occlusions and other peripheral applications.
Ferdinand Kiemeneij, M.D., Ph.D., from Onze Lieve Vrouwe Gasthius
(OLVG) in Amsterdam will present "Stereotaxis experience at OLVG: The First
500 Patients;" Robert Jan Van Geuns, M.D., Thoraxcenter at Erasmus Medical
Center in Rotterdam, will present "Integration of MSCT Imaging in Coronary
|SOURCE Stereotaxis, Inc.|
Copyright©2007 PR Newswire.
All rights reserved